About
A scientist at a small biotech and a scientist at big pharma are asking the same questions. They don't have the same tools.
That's the gap Motif was built to close.
Every year, millions of patients receive treatments that don't work because we lack the biomarkers to predict response. The knowledge to help them exists, scattered across millions of papers and dozens of databases. Surfacing it takes months of manual work that most research teams can't afford.
Ask your research question in plain English. Motif turns literature into structured, cross-referenced, cited biomarker associations, building an interactive knowledge graph that becomes your organization's biomarker intelligence layer: searchable, cumulative, and yours.
38,000,000+ articles indexed
Team
A viro-oncologist who engineered therapies to treat patient tumors. An epidemiologist who turned citizen science into outbreak intelligence across the Netherlands and Spain. They met the same wall in the lab: the evidence to move science forward was already published, but only the best-resourced teams could assemble it fast enough. Motif is what they built instead.
CEO / CTO
Marco spent years building patient-derived tumor models, profiling molecular response, and engineering oncolytic viruses for pancreatic cancer. Work where the right biomarker is the difference between a trial that learns and one that wastes years. As CEO and CTO, he builds the platform he wished existed every time he opened PubMed.
COO / CMO
Ayat turned crowdsourced surveillance into real epidemiology across Europe, then watched strong science stall for lack of infrastructure, not ideas. As COO and CMO, she scales Motif so researchers everywhere get the evidence assembly that used to require a dedicated team and a six-figure budget.
Our Values
Every result is cited and scored. You can trace any finding back to its original source with PMIDs. We never guess. We show you the evidence.
You see exactly where each finding comes from. No black boxes. Just clear, auditable results you can trust for grants and publications.
The tools and data that do what Motif does cost hundreds of dollars per run or require a six-figure contract. That makes them accessible to roughly 12 pharma companies. Motif is built for the other 1.75 million biomedical researchers.
Join the waitlist for early access to the Biomarker Intelligence Platform.
Explore our biomarker intelligence features or read insights on biomarker evidence.